ns2.latinforalla.net Open in urlscan Pro
172.67.133.36  Public Scan

Form analysis
0 forms found in the DOM

Text Content

STATINS PROTECT SMOKERS FROM LUNG DAMAGE

21 04 2016

Statins, the widely used class of drugs for cholesterol management, are now
showing promising results in slowing smoking-induced lung damage. In a new study
presented at CHEST 2006, the 72nd annual international scientific assembly of
the American College of Chest Physicians (ACCP), current and former smokers who
used statins had lower lung function decline than those not using statins,
regardless of whether patients continued or stopped smoking.

"Until now, no medication has...


PERVASIS THERAPEUTICS RECEIVES FDA CLEARANCE FOR PIVOTAL PHASE 3 TRIAL OF
VASCUGEL(R)

20 04 2016

Pervasis Therapeutics, Inc. announced that it has reached an agreement with the
U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3
clinical trial for Vascugel®, an investigational new drug for the prevention of
hemodialysis access graft failure. The agreement was made under the FDA's
Special Protocol Assessment (SPA) procedure. Pervasis expects to initiate the
study in 2010.

"We are pleased that the FDA approved the SPA agreement and are confident that
we now ...


GLOBAL CONFERENCE FOCUSES ON HIV/TB CO-EPIDEMIC CHALLENGES; REPORT FINDS
INTERNATIONAL SPENDING ON TB RESEARCH ONLY SLIGHTLY INCREASING

19 04 2016

Conference delegates at the 38th Union World Conference on Lung Health in Cape
Town, South Africa, that began on Thursday are focusing on challenges presented
by the HIV/TB co-epidemic, the AP/Google reports. Although about one-third of
people living with HIV worldwide have TB, the two diseases often are treated
separately, according to the AP/Google Nullis, AP/Google, 11/7).

About 3,000 HIV/AIDS researchers, government ministers, health officials,
advocates and people living with the di...


NEW STROKE-PREVENTION DRUG UNLIKELY TO BE COST-EFFECTIVE EXCEPT IN PATIENTS AT
HIGH RISK OF BLEEDING

18 04 2016

A new study has shown a stroke-prevention drug designed to be an improvement
over prior treatments is less cost-effective for most patients than warfarin,
the blood thinner with a 50-year history of helping prevent blood clots and
strokes. The study, conducted by researchers at Washington University School of
Medicine in St. Louis found, however, that the new drug would be cost-effective
for those atrial fibrillation patients whose risk of bleeding is high.

The findings are reported ...


STUDY SHEDS LIGHT ON ANGIOGENESIS INHIBITORS, POINTS TO LIMITATIONS, SOLUTIONS

17 04 2016

A new generation of cancer drugs designed to starve tumors of their blood supply
- called "angiogenesis inhibitors" - succeeds at first, but then promotes more
invasive cancer growth - sometimes with a higher incidence of metastases,
according to a new study in animals. The research clarifies similar findings in
other animal studies and is consistent with some early evidence from a small
number of clinical trials with cancer patients.

"People have thought that angiogenesis-inhibiting th...

LINKS

 * Home
 * Sitemap

RECENT POSTS

 * Statins Protect Smokers From Lung Damage
 * Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of
   Vascugel(R)
 * Global Conference Focuses On HIV/TB Co-Epidemic Challenges; Report Finds
   International Spending On TB Research Only Slightly Increasing
 * New stroke-prevention drug unlikely to be cost-effective except in patients
   at high risk of bleeding
 * Study Sheds Light On Angiogenesis Inhibitors, Points To Limitations,
   Solutions
 * Report On SIU 2007 Paris: Innovations In The Treatment Of Stress Urinary
   Incontinence
 * Seniors Demand World Class Care, Financial Security, Equality In Work And An
   End To Ageism, Australia
 * Zypadhera(TM) Receives Positive Opinion From The European Committee For
   Medicinal Products For Human Use (CHMP) For Treatment Of Schizophrenia
 * Study Shows How Light Receptors In Eye Play Key Role In Setting Biological
   Clock
 * Low Dose And High Dose Ketoconazole Demonstrate Similar Outcomes In Patients
   With Androgen-Independent Prostate Cancer
 * Gilbert Hospital Continues Cutting Edge Treatments



TAG CLOUD